Rywn can now be used for lymphoblastic leukemia and lymphoma Aug 24, 2021 News cancer, leukemia, oncology June 20, 2021 marked the approval of Rylaze (Asparaginase erwinia chrysanthemi (recombinant)-rywn) by the U.S. […] Read More
